Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-05

Clinical Trial Update: Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure [Phase 2]

View source ↗

Summary

The document reports a Phase 2 clinical trial evaluating the efficacy and safety of ALF-5755 in patients with acute liver failure due to nonacetaminophen severe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALF-5755 (ALF-5755)

Snippet

Sponsor: Alfact Innovation | Conditions: Liver Failure, Acute | Phase 2 | Status: UNKNOWN